SynthesisJournal of the American Geriatrics Society2022

Newer glucose-lowering drugs and risk of dementia: A meta-analysis of cardiovascular outcome trials.

Huilin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.